Ravi Viswanathan Insider Trading Transactions
Get free email notifications about insider trading for Ravi Viswanathan.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Ravi Viswanathan. Ravi Viswanathan is 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in Workday, Inc. ($WDAY) and 10% Owner in AEROHIVE NETWORKS, INC ($HIVE) and 10% Owner in BOX INC ($BOX) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Millennial Media Inc. ($MM) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in Clovis Oncology, Inc. ($CLVS) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Omthera Pharmaceuticals, Inc. ($OMTH) and Director in Omthera Pharmaceuticals, Inc. ($OMTH) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in CVENT INC ($CVT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Dermira, Inc. ($DERM) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Surface Oncology, Inc. ($SURF).
Latest Insider Trading Transactions of Ravi Viswanathan
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, ADAP, HIVE, APPN, ARDX, AVEO, BOX, CRCM, CASC, CERC, CLVS, CVT, DERM, ESTC, EPZM, ILIU, LOXO, MRSN, MM, MULE, OMTH, RARX, RYTM, ROKA, SURF, SYBX, TSRO, TCON, WDAY
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 10 2018 | ESTC | Elastic N.V. | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 1,528,117 | 0 | 0 | |
Oct 10 2018 | ESTC | Elastic N.V. | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 4,155,995 | 0 | 0 | |
Oct 10 2018 | ESTC | Elastic N.V. | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 1,528,117 | 0 | 1,528,117 | 0 to 1.5 M |
Oct 10 2018 | ESTC | Elastic N.V. | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 4,155,995 | 0 | 4,155,995 | 0 to 4.2 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.67 | 12,000,000 | 20,000,400 | 12,000,000 | 0 to 12 M |
Sep 10 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
Aug 22 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.26 | 663,716 | 1,499,998 | 18,698,038 | 18 M to 18.7 M (+3.68 %) |
Jul 20 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.00 | 50,600 | 101,165 | 18,034,322 | 18 M to 18 M (+0.28 %) |
Jul 20 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.95 | 200,000 | 390,580 | 17,983,722 | 17.8 M to 18 M (+1.12 %) |
Jun 28 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.10 | 187,130 | 392,692 | 17,783,722 | 17.6 M to 17.8 M (+1.06 %) |
Jun 28 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.15 | 5,295 | 11,384 | 17,596,592 | 17.6 M to 17.6 M (+0.03 %) |
May 30 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.15 | 275 | 591 | 17,591,297 | 17.6 M to 17.6 M (0.00 %) |
May 30 2018 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Grant | A | 4.00 | 416,667 | 1,666,668 | 3,082,186 | 2.7 M to 3.1 M (+15.63 %) |
May 30 2018 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Grant | A | 4.00 | 416,666 | 1,666,664 | 3,082,186 | 2.7 M to 3.1 M (+15.63 %) |
May 21 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.14 | 32,200 | 69,059 | 17,591,022 | 17.6 M to 17.6 M (+0.18 %) |
May 21 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.14 | 20,100 | 42,928 | 17,558,822 | 17.5 M to 17.6 M (+0.11 %) |
May 21 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.13 | 184,179 | 391,436 | 17,538,722 | 17.4 M to 17.5 M (+1.06 %) |
May 10 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.13 | 70,873 | 151,250 | 17,354,543 | 17.3 M to 17.4 M (+0.41 %) |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 858,978 | 0 | 0 | |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 2,576,939 | 0 | 0 | |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 12,679,970 | 0 | 0 | |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Sell | U | 0.00 | 858,978 | 0 | 0 | 859 K to 0 (-100.00 %) |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 858,978 | 0 | 858,978 | 0 to 859 K |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Sell | U | 0.00 | 2,576,939 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 2,576,939 | 0 | 2,576,939 | 0 to 2.6 M |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Sell | U | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
May 09 2018 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 12,679,970 | 0 | 12,679,970 | 0 to 12.7 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
Apr 23 2018 | SURF | Surface Oncology, ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.46 | 203,200 | 499,994 | 17,283,670 | 17.1 M to 17.3 M (+1.19 %) |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.43 | 32,100 | 78,099 | 17,080,470 | 17 M to 17.1 M (+0.19 %) |
Apr 10 2018 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.24 | 685,676 | 1,536,943 | 17,048,370 | 16.4 M to 17 M (+4.19 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.92 | 6,000,000 | 11,500,200 | 79,978,672 | 74 M to 80 M (+8.11 %) |
Mar 28 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.90 | 571,164 | 1,087,553 | 73,978,672 | 73.4 M to 74 M (+0.78 %) |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
Mar 27 2018 | TCON | Tracon Pharmaceuti ... | Viswanathan Ravi | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
Mar 23 2018 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
Mar 13 2018 | CASC | Cascadian Therapeu ... | Viswanathan Ravi | 10% Owner | Sell | U | 0.00 | 10,882,574 | 0 | 0 | 10.9 M to 0 (-100.00 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 59.82 | 3,159 | 188,957 | 739,516 | 736.4 K to 739.5 K (+0.43 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 59.76 | 4,311 | 257,643 | 736,357 | 732 K to 736.4 K (+0.59 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 59.15 | 400 | 23,658 | 732,046 | 731.6 K to 732 K (+0.05 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 58.28 | 7,557 | 440,433 | 731,646 | 724.1 K to 731.6 K (+1.04 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 57.34 | 4,465 | 256,043 | 724,089 | 719.6 K to 724.1 K (+0.62 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 56.66 | 1,020 | 57,794 | 719,624 | 718.6 K to 719.6 K (+0.14 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 55.01 | 1,600 | 88,015 | 718,604 | 717 K to 718.6 K (+0.22 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 54.32 | 6,575 | 357,165 | 717,004 | 710.4 K to 717 K (+0.93 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 59.82 | 12,634 | 755,708 | 9,681,129 | 9.7 M to 9.7 M (+0.13 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 59.76 | 17,248 | 1,030,813 | 9,668,495 | 9.7 M to 9.7 M (+0.18 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 59.15 | 1,600 | 94,634 | 9,651,247 | 9.6 M to 9.7 M (+0.02 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 58.28 | 30,321 | 1,767,153 | 9,649,647 | 9.6 M to 9.6 M (+0.32 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 57.34 | 17,859 | 1,024,114 | 9,619,326 | 9.6 M to 9.6 M (+0.19 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 56.66 | 4,080 | 231,174 | 9,601,467 | 9.6 M to 9.6 M (+0.04 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 55.01 | 6,399 | 352,005 | 9,597,387 | 9.6 M to 9.6 M (+0.07 %) |
Mar 06 2018 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 54.32 | 26,304 | 1,428,875 | 9,590,988 | 9.6 M to 9.6 M (+0.28 %) |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 3.30 | 1,818,000 | 5,999,400 | 0 | |
Feb 22 2018 | CASC | Cascadian Therapeu ... | Viswanathan Ravi | 10% Owner | Buy | C | 3.30 | 1,818,000 | 5,999,400 | 10,882,574 | 9.1 M to 10.9 M (+20.06 %) |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 2,724,202 | 0 | 0 | |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 509 | 0 | 509 | 0 to 509 |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 1,014 | 0 | 1,014 | 0 to 1 K |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 13,621 | 0 | 0 | 13.6 K to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 13,621 | 0 | 13,621 | 0 to 13.6 K |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 27,242 | 0 | 0 | 27.2 K to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 27,242 | 0 | 27,242 | 0 to 27.2 K |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 2,724,202 | 0 | 0 | 2.7 M to 0 (-100.00 %) |
Feb 15 2018 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 2,724,202 | 0 | 2,724,202 | 0 to 2.7 M |
Jan 26 2018 | MIRN | SYNLOGIC, INC. | Viswanathan Ravi | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
Nov 27 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 569,620 | 0 | 2,724,202 | |
Nov 27 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Sell | S | 19.49 | 569,620 | 11,101,894 | 0 | 569.6 K to 0 (-100.00 %) |
Nov 27 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 569,620 | 0 | 569,620 | 0 to 569.6 K |
Nov 21 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 2,820,516 | 0 | 3,293,822 | |
Nov 21 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Sell | S | 19.49 | 2,820,516 | 54,971,857 | 0 | 2.8 M to 0 (-100.00 %) |
Nov 21 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 2,820,516 | 0 | 2,820,516 | 0 to 2.8 M |
Nov 08 2017 | CRCM | Care.com Inc | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 336 | 0 | 336 | 0 to 336 |
Nov 08 2017 | CRCM | Care.com Inc | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Nov 08 2017 | CRCM | Care.com Inc | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Nov 08 2017 | CRCM | Care.com Inc | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 1,000,000 | 0 | 2,256,013 | 3.3 M to 2.3 M (-30.71 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 2,927,708 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 1,402,870 | 0 | 0 | |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | Viswanathan Ravi | 10% Owner | Buy | P | 17.00 | 550,000 | 9,350,000 | 4,909,956 | 4.4 M to 4.9 M (+12.61 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 2,927,708 | 0 | 4,359,956 | 1.4 M to 4.4 M (+204.41 %) |
Oct 10 2017 | RYTM | RHYTHM PHARMACEUTI ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 1,402,870 | 0 | 1,432,248 | 29.4 K to 1.4 M (+4,775.24 %) |
Aug 30 2017 | MIRN | SYNLOGIC, INC. | Viswanathan Ravi | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 2,216,626 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 18,001,419 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 11,931,173 | 0 | 0 | |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | Viswanathan Ravi | 10% Owner | Buy | P | 15.00 | 1,000,000 | 15,000,000 | 8,140,138 | 7.1 M to 8.1 M (+14.01 %) |
Jul 06 2017 | MRSN | Mersana Therapeuti ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 7,140,138 | 0 | 7,140,138 | 0 to 7.1 M |
May 31 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 6,114,338 | |
May 31 2017 | APPN | APPIAN CORP | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 0 | |
Mar 29 2017 | AVEO | AVEO PHARMACEUTICA ... | Viswanathan Ravi | 10% Owner | Buy | P | 0.50 | 6,000,000 | 3,000,000 | 16,362,694 | 10.4 M to 16.4 M (+57.90 %) |
Mar 28 2017 | ADAP | Adaptimmune Therap ... | Viswanathan Ravi | 10% Owner | Buy | P | 0.70 | 12,870,000 | 9,009,000 | 72,139,000 | 59.3 M to 72.1 M (+21.71 %) |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | J | 0.00 | 858,978 | 0 | 858,978 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | J | 0.00 | 2,576,939 | 0 | 2,576,939 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | J | 0.00 | 12,679,970 | 0 | 12,679,970 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 227,125 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 631,853 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 681,377 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 1,895,562 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 605,668 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 2,064,048 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 8,000,038 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 1,689,436 | 0 | 0 | |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 858,978 | 0 | 0 | 859 K to 0 (-100.00 %) |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 858,978 | 0 | 858,978 | 0 to 859 K |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 2,576,939 | 0 | 0 | 2.6 M to 0 (-100.00 %) |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 2,576,939 | 0 | 2,576,939 | 0 to 2.6 M |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Sell | J | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
Mar 22 2017 | MULE | MULESOFT, INC | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 12,359,190 | 0 | 12,679,970 | 320.8 K to 12.7 M (+3,852.86 %) |
Dec 19 2016 | AKAO | Achaogen Inc | Viswanathan Ravi | 10% Owner | Buy | P | 13.50 | 500,000 | 6,750,000 | 5,215,128 | 4.7 M to 5.2 M (+10.60 %) |
Nov 29 2016 | TCON | Tracon Pharmaceuti ... | Viswanathan Ravi | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 4,362,472 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 4,689,657 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 12,447,605 | 0 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Option Exercise | X | 0.07 | 80,658 | 5,646 | 0 | |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Buy | P | 13.00 | 338,462 | 4,400,006 | 3,490,073 | 3.2 M to 3.5 M (+10.74 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 623,210 | 0 | 3,151,611 | 2.5 M to 3.2 M (+24.65 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 669,951 | 0 | 2,528,401 | 1.9 M to 2.5 M (+36.05 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 1,778,227 | 0 | 1,858,450 | 80.2 K to 1.9 M (+2,216.60 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Sell | S | 13.00 | 435 | 5,655 | 80,223 | 80.7 K to 80.2 K (-0.54 %) |
Oct 31 2016 | RARX | Ra Pharmaceuticals ... | Viswanathan Ravi | 10% Owner | Buy | X | 0.07 | 80,658 | 5,646 | 80,658 | 0 to 80.7 K |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 0.70 | 5,714,286 | 4,000,000 | 5,714,286 | |
Sep 23 2016 | ROKA | Roka BioScience, I ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 0.70 | 4,000 | 2,800 | 4,000 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Viswanathan Ravi | 10% Owner | Option Exercise | P | 0.10 | 20,120,724 | 2,000,000 | 20,120,724 | |
Aug 02 2016 | ILIU | INTERLEUKIN GENETI ... | Viswanathan Ravi | 10% Owner | Buy | P | 0.10 | 20,120,724 | 2,000,000 | 55,418,811 | 35.3 M to 55.4 M (+57.00 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Buy | P | 8.73 | 763,650 | 6,666,665 | 2,665,519 | 1.9 M to 2.7 M (+40.15 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Buy | P | 8.73 | 763,651 | 6,666,673 | 2,665,520 | 1.9 M to 2.7 M (+40.15 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Buy | P | 8.73 | 763,650 | 6,666,665 | 2,665,519 | 1.9 M to 2.7 M (+40.15 %) |
Jul 20 2016 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Buy | P | 8.73 | 763,651 | 6,666,673 | 2,665,520 | 1.9 M to 2.7 M (+40.15 %) |
Mar 18 2016 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 35.19 | 710,429 | 24,999,997 | 710,429 | 0 to 710.4 K |
Mar 18 2016 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 35.19 | 710,429 | 24,999,997 | 9,564,684 | 8.9 M to 9.6 M (+8.02 %) |
Jan 14 2016 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,901,869 | 1.4 M to 1.9 M (+35.67 %) |
Jan 14 2016 | ARDX | ARDELYX, INC. | Viswanathan Ravi | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,901,869 | 1.4 M to 1.9 M (+35.67 %) |
Jan 12 2016 | EPZM | Epizyme, Inc. | Viswanathan Ravi | 10% Owner | Buy | P | 9.00 | 1,111,111 | 9,999,999 | 5,854,351 | 4.7 M to 5.9 M (+23.43 %) |
Oct 20 2015 | CERC | Cerecor Inc. | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 16,638,880 | 0 | 0 | |
Oct 20 2015 | CERC | Cerecor Inc. | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 594,245 | 0 | 594,245 | 0 to 594.2 K |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Option Exercise | C | 0.00 | 1,241,650 | 0 | 0 | |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,971,517 | 2.1 M to 3 M (+40.54 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 31,650 | 0 | 2,114,375 | 2.1 M to 2.1 M (+1.52 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 583,559 | 0 | 2,082,725 | 1.5 M to 2.1 M (+38.93 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | J | 0.00 | 257,516 | 0 | 1,499,166 | 1.2 M to 1.5 M (+20.74 %) |
Oct 06 2015 | MIRN | Mirna Therapeutics ... | Viswanathan Ravi | 10% Owner | Buy | C | 0.00 | 1,241,650 | 0 | 1,241,650 | 0 to 1.2 M |
Jun 15 2015 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Sell | S | 54.96 | 553 | 30,393 | 0 | 553 to 0 (-100.00 %) |
Jun 15 2015 | TSRO | TESARO, Inc. | Viswanathan Ravi | 10% Owner | Sell | S | 54.53 | 336 | 18,323 | 553 | 889 to 553 (-37.80 %) |